Catalyst Wire Dossier Catalyst Wire Dossier

Alovudine

alovudine · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alovudine, covering 2014-09-05 to 2014-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure [Phase 2]

See pricing